Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Accor (ACCP.PA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2022-03-30	29.64	34.00	Neutral
2022-09-09	23.97	25.00	Neutral
2022-10-31	24.24	26.00	Neutral
2023-02-27	31.74	34.00	Neutral
2023-05-01	32.12	35.55	Neutral
2023-07-04	33.81	37.70	Neutral
2023-07-31	34.29	37.90	Neutral
2024-02-05	36.62	40.35	Neutral
2024-02-27	40.49	50.00	Buy
2024-07-30	36.04	47.25	Buy
2024-10-28	42.27	48.75	Buy
2024-12-09	45.65	54.00	Buy
2025-02-14	50.46	61.45	Buy

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.